Showing results (371-380 of 390) with videos related to

Sort By:
Pageof 39
The British Journal of Dermatology|April 9, 2024
Midfacial toddler excoriation syndrome (MiTES): case series, diagnostic criteria and evidence for a pathogenic mechanismNivedita Sarveswaran, Yunisa Pamela, Akhila A N Reddy, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profilesC C Chan, S Boyce, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitorP Prasit, Z Wang, C Brideau, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2D Riendeau, M D Percival, C Brideau, et al.
JAMA Dermatology|June 16, 2021
Association of Demographic Factors and Infantile Hemangioma Characteristics With Risk of PHACE SyndromeColleen H Cotton, Jusleen Ahluwalia, Daniel M Balkin, et al.
JAMA Dermatology|December 12, 2019
Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE SyndromeGerilyn M Olsen, Leanna M Hansen, Nicole S Stefanko, et al.
Journal of Developmental Origins of Health and Disease|December 8, 2015
Body adiposity and bone parameters of male rats from mothers fed diet containing flaxseed flour during lactationC A S da Costa, P C A da Silva, D C Ribeiro, et al.
Annals of Medicine and Surgery (2012)|December 28, 2020
Prospective, multicenter study of P4HB (Phasix™) mesh for hernia repair in cohort at risk for complications: 3-Year follow-upJohn Scott Roth, Gary J Anthone, Don J Selzer, et al.
The American Journal of Cardiology|November 6, 2001
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint dataV J Dzau, K Bernstein, D Celermajer, et al.
Journal of the American College of Surgeons|September 14, 2022
Long-Term, Prospective, Multicenter Study of Poly-4-Hydroxybutyrate Mesh (Phasix Mesh) for Hernia Repair in Cohort at Risk for Complication: 60-Month Follow-UpJohn Scott Roth, Gary J Anthone, Don J Selzer, et al.
Pageof 39